The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Geriatric Medicines Market Research Report 2024
Synopsis
Geriatric medicine is a growing medical specialty that focuses on the care and treatment of older people.
The global Geriatric Medicines market was valued at US$ 712450 million in 2023 and is anticipated to reach US$ 1150460 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030.
The Geriatric Medicines market is witnessing substantial growth due to the global increase in the elderly population. With aging, individuals are prone to chronic diseases and conditions, leading to a higher demand for geriatric medicines. Pharmaceutical companies are focusing on developing medications that address age-related health issues like cardiovascular diseases, arthritis, dementia, and diabetes. The market is also driven by advancements in medical research, personalized medicine, and improved healthcare access for the elderly. However, challenges exist in terms of ensuring medication safety, addressing polypharmacy concerns, and affordability for older adults. Despite these challenges, the Geriatric Medicines market presents significant opportunities for pharmaceutical companies to cater to the healthcare needs of an aging population.
This report aims to provide a comprehensive presentation of the global market for Geriatric Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Geriatric Medicines.
Report Scope
The Geriatric Medicines market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Geriatric Medicines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Geriatric Medicines companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly and Company
AstraZeneca
Boehringer Ingelheim
Abbott Laboratories
Sanofi
Bristol-Myers Squibb
Merck
Novartis
Pfizer
GSK
Segment by Type
Analgesics
Antihypertensives
Statins
Antidiabetics
Proton Pump Inhibitor
Anticoagulant
Antipsychotics
Antidepressants
Segment by Application
Cardiovascular diseases
Arthritis
Neurological Disorders
Cancer
Osteoporosis
Respiratory
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Geriatric Medicines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Geriatric medicine is a growing medical specialty that focuses on the care and treatment of older people.
The global Geriatric Medicines market was valued at US$ 712450 million in 2023 and is anticipated to reach US$ 1150460 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030.
The Geriatric Medicines market is witnessing substantial growth due to the global increase in the elderly population. With aging, individuals are prone to chronic diseases and conditions, leading to a higher demand for geriatric medicines. Pharmaceutical companies are focusing on developing medications that address age-related health issues like cardiovascular diseases, arthritis, dementia, and diabetes. The market is also driven by advancements in medical research, personalized medicine, and improved healthcare access for the elderly. However, challenges exist in terms of ensuring medication safety, addressing polypharmacy concerns, and affordability for older adults. Despite these challenges, the Geriatric Medicines market presents significant opportunities for pharmaceutical companies to cater to the healthcare needs of an aging population.
This report aims to provide a comprehensive presentation of the global market for Geriatric Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Geriatric Medicines.
Report Scope
The Geriatric Medicines market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Geriatric Medicines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Geriatric Medicines companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly and Company
AstraZeneca
Boehringer Ingelheim
Abbott Laboratories
Sanofi
Bristol-Myers Squibb
Merck
Novartis
Pfizer
GSK
Segment by Type
Analgesics
Antihypertensives
Statins
Antidiabetics
Proton Pump Inhibitor
Anticoagulant
Antipsychotics
Antidepressants
Segment by Application
Cardiovascular diseases
Arthritis
Neurological Disorders
Cancer
Osteoporosis
Respiratory
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Geriatric Medicines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Geriatric Medicines Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Analgesics
1.2.3 Antihypertensives
1.2.4 Statins
1.2.5 Antidiabetics
1.2.6 Proton Pump Inhibitor
1.2.7 Anticoagulant
1.2.8 Antipsychotics
1.2.9 Antidepressants
1.3 Market by Application
1.3.1 Global Geriatric Medicines Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cardiovascular diseases
1.3.3 Arthritis
1.3.4 Neurological Disorders
1.3.5 Cancer
1.3.6 Osteoporosis
1.3.7 Respiratory
1.3.8 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Geriatric Medicines Market Perspective (2019-2030)
2.2 Geriatric Medicines Growth Trends by Region
2.2.1 Global Geriatric Medicines Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Geriatric Medicines Historic Market Size by Region (2019-2024)
2.2.3 Geriatric Medicines Forecasted Market Size by Region (2025-2030)
2.3 Geriatric Medicines Market Dynamics
2.3.1 Geriatric Medicines Industry Trends
2.3.2 Geriatric Medicines Market Drivers
2.3.3 Geriatric Medicines Market Challenges
2.3.4 Geriatric Medicines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Geriatric Medicines Players by Revenue
3.1.1 Global Top Geriatric Medicines Players by Revenue (2019-2024)
3.1.2 Global Geriatric Medicines Revenue Market Share by Players (2019-2024)
3.2 Global Geriatric Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Geriatric Medicines Revenue
3.4 Global Geriatric Medicines Market Concentration Ratio
3.4.1 Global Geriatric Medicines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Geriatric Medicines Revenue in 2023
3.5 Geriatric Medicines Key Players Head office and Area Served
3.6 Key Players Geriatric Medicines Product Solution and Service
3.7 Date of Enter into Geriatric Medicines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Geriatric Medicines Breakdown Data by Type
4.1 Global Geriatric Medicines Historic Market Size by Type (2019-2024)
4.2 Global Geriatric Medicines Forecasted Market Size by Type (2025-2030)
5 Geriatric Medicines Breakdown Data by Application
5.1 Global Geriatric Medicines Historic Market Size by Application (2019-2024)
5.2 Global Geriatric Medicines Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Geriatric Medicines Market Size (2019-2030)
6.2 North America Geriatric Medicines Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Geriatric Medicines Market Size by Country (2019-2024)
6.4 North America Geriatric Medicines Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Geriatric Medicines Market Size (2019-2030)
7.2 Europe Geriatric Medicines Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Geriatric Medicines Market Size by Country (2019-2024)
7.4 Europe Geriatric Medicines Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Geriatric Medicines Market Size (2019-2030)
8.2 Asia-Pacific Geriatric Medicines Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Geriatric Medicines Market Size by Region (2019-2024)
8.4 Asia-Pacific Geriatric Medicines Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Geriatric Medicines Market Size (2019-2030)
9.2 Latin America Geriatric Medicines Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Geriatric Medicines Market Size by Country (2019-2024)
9.4 Latin America Geriatric Medicines Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Geriatric Medicines Market Size (2019-2030)
10.2 Middle East & Africa Geriatric Medicines Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Geriatric Medicines Market Size by Country (2019-2024)
10.4 Middle East & Africa Geriatric Medicines Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Detail
11.1.2 Eli Lilly and Company Business Overview
11.1.3 Eli Lilly and Company Geriatric Medicines Introduction
11.1.4 Eli Lilly and Company Revenue in Geriatric Medicines Business (2019-2024)
11.1.5 Eli Lilly and Company Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Geriatric Medicines Introduction
11.2.4 AstraZeneca Revenue in Geriatric Medicines Business (2019-2024)
11.2.5 AstraZeneca Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Geriatric Medicines Introduction
11.3.4 Boehringer Ingelheim Revenue in Geriatric Medicines Business (2019-2024)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Detail
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Geriatric Medicines Introduction
11.4.4 Abbott Laboratories Revenue in Geriatric Medicines Business (2019-2024)
11.4.5 Abbott Laboratories Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Geriatric Medicines Introduction
11.5.4 Sanofi Revenue in Geriatric Medicines Business (2019-2024)
11.5.5 Sanofi Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Detail
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Geriatric Medicines Introduction
11.6.4 Bristol-Myers Squibb Revenue in Geriatric Medicines Business (2019-2024)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Geriatric Medicines Introduction
11.7.4 Merck Revenue in Geriatric Medicines Business (2019-2024)
11.7.5 Merck Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis Geriatric Medicines Introduction
11.8.4 Novartis Revenue in Geriatric Medicines Business (2019-2024)
11.8.5 Novartis Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Geriatric Medicines Introduction
11.9.4 Pfizer Revenue in Geriatric Medicines Business (2019-2024)
11.9.5 Pfizer Recent Development
11.10 GSK
11.10.1 GSK Company Detail
11.10.2 GSK Business Overview
11.10.3 GSK Geriatric Medicines Introduction
11.10.4 GSK Revenue in Geriatric Medicines Business (2019-2024)
11.10.5 GSK Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
